Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

3.

Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.

Fujioka Y, Kadono K, Fujie Y, Metsugi Y, Ogawara K, Higaki K, Kimura T.

J Control Release. 2007 Jun 4;119(2):222-8. Epub 2007 Mar 13.

PMID:
17442444
4.

In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.

Higashino H, Hasegawa T, Yamamoto M, Matsui R, Masaoka Y, Kataoka M, Sakuma S, Yamashita S.

Mol Pharm. 2014 Mar 3;11(3):746-54. doi: 10.1021/mp400465p. Epub 2014 Feb 6.

PMID:
24460473
5.

Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.

Fujioka Y, Metsugi Y, Ogawara K, Higaki K, Kimura T.

Int J Pharm. 2008 Mar 20;352(1-2):36-43. Epub 2007 Oct 16.

PMID:
18037251
6.

Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.

Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, Aso Y, Yamashita S.

Pharm Res. 2008 Oct;25(10):2334-44. doi: 10.1007/s11095-008-9637-9. Epub 2008 Jun 17.

PMID:
18560998
7.

Fast-dissolving microparticles fail to show improved oral bioavailability.

Wong SM, Kellaway IW, Murdan S.

J Pharm Pharmacol. 2006 Oct;58(10):1319-26.

PMID:
17034654
8.
9.

Is the full potential of the biopharmaceutics classification system reached?

Bergström CA, Andersson SB, Fagerberg JH, Ragnarsson G, Lindahl A.

Eur J Pharm Sci. 2014 Jun 16;57:224-31. doi: 10.1016/j.ejps.2013.09.010. Epub 2013 Sep 25.

PMID:
24075971
10.

Improving the high variable bioavailability of griseofulvin by SEDDS.

Arida AI, Al-Tabakha MM, Hamoury HA.

Chem Pharm Bull (Tokyo). 2007 Dec;55(12):1713-9.

11.

In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.

Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C.

Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.

PMID:
23727464
12.

Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.

Miyaji Y, Fujii Y, Takeyama S, Kawai Y, Kataoka M, Takahashi M, Yamashita S.

Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13.

PMID:
27031624
13.

Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.

Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S.

Pharm Res. 2006 Jun;23(6):1144-56. Epub 2006 May 25.

PMID:
16715363
14.

Effect of chitosan on gastrointestinal absorption of water-insoluble drugs following oral administration in rats.

Nadai M, Tajiri C, Yoshizumi H, Suzuki Y, Zhao YL, Kimura M, Tsunekawa Y, Hasegawa T.

Biol Pharm Bull. 2006 Sep;29(9):1941-6.

15.

Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.

Lehto P, Kortejärvi H, Liimatainen A, Ojala K, Kangas H, Hirvonen J, Tanninen VP, Peltonen L.

Eur J Pharm Biopharm. 2011 Aug;78(3):531-8. doi: 10.1016/j.ejpb.2011.02.007. Epub 2011 Feb 15.

PMID:
21329757
16.

Impact of Luminal Fluid Volume on the Drug Absorption After Oral Administration: Analysis Based on In Vivo Drug Concentration-Time Profile in the Gastrointestinal Tract.

Tanaka Y, Goto T, Kataoka M, Sakuma S, Yamashita S.

J Pharm Sci. 2015 Sep;104(9):3120-7. doi: 10.1002/jps.24433. Epub 2015 Mar 27.

PMID:
25821198
17.

pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.

Varma MV, Gardner I, Steyn SJ, Nkansah P, Rotter CJ, Whitney-Pickett C, Zhang H, Di L, Cram M, Fenner KS, El-Kattan AF.

Mol Pharm. 2012 May 7;9(5):1199-212. doi: 10.1021/mp2004912. Epub 2012 Apr 26.

PMID:
22489626
18.

In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.

Dressman JB, Reppas C.

Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S73-80. Review.

PMID:
11033429
19.
20.

A modified physiological BCS for prediction of intestinal absorption in drug discovery.

Zaki NM, Artursson P, Bergström CA.

Mol Pharm. 2010 Oct 4;7(5):1478-87. doi: 10.1021/mp100124f. Epub 2010 Sep 1.

PMID:
20734997

Supplemental Content

Support Center